Boeing’s fundamentals have been improving, but the recent spike up in the stock seems to be more about investors being afraid not to own it, Vertical Research said. Source link Steve Gelsi
Boeing’s stock has been surging. Here’s why it has become a FOMO play. Read More »
On Thursday, the company said it’ll handle the extra costs tied to the current tariff regime and still deliver its full-year earnings targets. Source link Steve Gelsi
Advance Auto Parts’ stock rockets as tariffs didn’t change the earnings outlook Read More »
The market for initial public offerings continues to gear up after an absence of deals in recent weeks. Source link Steve Gelsi
Two software companies are going public. The IPO market is getting up off the mat. Read More »
Lowe’s said it faces housing-market headwinds and near-term economic uncertainty, but kept its 2025 earnings projections in place. Source link Steve Gelsi
Lowe’s sales fall, as customers are avoiding products that cost $500 or more Read More »
The launch comes after JPMorgan Chase Chief Executive Jamie Dimon said in his most recent annual letter to shareholders that investors face “the most perilous and complicated geopolitical and economic environment” since 1945. Source link Steve Gelsi
JPMorgan launches ‘special forces’ unit to protect investors from political risks Read More »
Quarterly sales and profit narrowly beat analyst estimates, but the retailer’s outlook falls short of projections. Source link Steve Gelsi
TJ Maxx parent’s stock falls after it warns of a profit shortfall on tariff costs Read More »
Amer Sports’ stock rockets toward a record as sports equipment and apparel maker’s brands are winning in China’s fast-growing premium sports and outdoor market. Source link Steve Gelsi
Arc’teryx, Salomon parent is doing what Nike isn’t: growing ‘very well’ in China Read More »
Underwear company adopts so-called poison pill after Australian activist shareholder Blundy switches stock-holding classification to active from passive. Source link Steve Gelsi
Victoria’s Secret moves to block activist investor from amassing controlling stake Read More »
Home Depot beat Wall Street’s first-quarter revenue and domestic same-store sales expectations, and maintained its full-year guidance. Source link Steve Gelsi
Home Depot’s long run of earnings beats has ended, but here’s why the stock is rising Read More »
Regeneron said it will continue uninterrupted service of 23andMe’s consumer genome services after its purchase closes as expected in the third quarter of this year. Source link Steve Gelsi
23andMe sells its most valuable asset. Regeneron promises to keep your DNA private. Read More »
